Introducing the Lifelong Health Study — Designed to create a more complete, realistic picture of human health
Verily is excited to announce the launch of the Lifelong Health Study. This Verily-sponsored research registry will continuously follow participants on their health journeys to provide a multi-dimensional view of how health changes over time, helping identify the many factors that shape long-term health and disease progression. Through fostering stronger participant engagement and relationships, capturing and integrating diverse, longitudinal real-world data (RWD), and helping bridge the gap between research and care, this study aims to transform real-world evidence generation for delivering on the promise of precision health.
Designed to gather RWD across a broad spectrum of participant populations in a flexible way, the Lifelong Health Study is an observational registry. This allows researchers — including pharmaceutical R&D teams — to construct a holistic picture of health journeys and disease states over time, along with the factors that influence them. The study’s Principal Investigator, Andrew Trister, MD, PhD, Verily's Chief Medical and Scientific Officer, explains, "Traditional research often relies on static, cross-sectional measures that fail to capture the dynamic nature of health. The Lifelong Health Study will help us characterize health as a continuous process, analyzing high-frequency, diverse data for understanding the individual trajectories that influence the two-way transition between wellness and disease.”
The Lifelong Health Study will also build an active community of consented and engaged participants — motivated for continued research — enabling outreach to relevant populations, transforming research from static data pulls into dynamic, ongoing conversations.
Building upon the foundation of the Verily-led Project Baseline, the Lifelong Health Study is another initiative that exemplifies Verily’s commitment to continued leadership in biomedical research to create a healthier future for all. Read on to learn more about the study launch, and register for a live webinar to learn more about our evidence capabilities from Verily experts.
Existing RWD is often like a low-resolution photograph with entire sections of pixels missing. By integrating high-frequency signals from devices and capturing day-to-day context directly from participants, Verily will help fill in those missing pixels, creating a much clearer and more actionable picture of individual health.
Erich Huang, MD, PhD,
Verily Associate Chief Clinical Officer
for Technology and Informatics
Supporting personal health and lifelong engagement
Verily Me is a free app that provides personalized health recommendations from licensed providers based on individual medical history across doctors and health systems — with 24/7 AI assistance to help individuals’ learn more about their health records.
Through this care app, Verily Me members can also choose to participate in the Lifelong Health Study, building a consented population that can be accessed for unlocking other research opportunities. Verily Me helps make study participation a more flexible, easy and convenient experience, while also fostering research involvement as active collaborators in their health journeys, in parallel. Health-management features, along with the immersive, intuitive design of the app — built with user-experience best practices — can foster stronger participant engagement in the Lifelong Health Study, leading to higher-quality, longitudinal data and reduced attrition.
All this marks a significant shift from episodic studies tied to physical or decentralized research sites to a continuous, participant-centric model that can reach people — anywhere, anytime — allowing researchers to deploy new ePROs surveys, collect new information from connected wearables, or even prompt participants to complete follow-up lab tests. This seamless link enables more rapid investigation of safety signals, understanding of treatment patterns, or gathering evidence to form new hypotheses.
Committed to transparency
A cornerstone of this approach is Verily’s commitment to transparency, ensuring participants don't simply understand what data is collected, but why it matters and how it contributes to shared scientific goals. This transparency is vital for building trust, which is foundational for scientific integrity and high-quality data. In this spirit of cultivating participant confidence and partnership, Verily intends to share novel insights and aggregate study results with participants. Beyond altruism and contributing to the healthcare’s future, this may enable greater understanding of our health, and potentially inspire people and their providers to make more informed healthcare decisions.
Consumer interest strongly supports this model, with a Verily-led survey of 2,000 consumers revealing that 58% are interested in joining health research studies via their smartphone, underscoring the relevance of this app-based, direct-to-consumer approach.1
Committed to privacy and security
Verily is highly committed to meeting applicable laws and regulations for health data privacy and security throughout every point of the Verily Me and Lifelong Health Study experiences. Lisa Lehmann, MD, PhD, and Verily's Medical Director for Clinical Research emphasizes, "Scientific progress depends on high-quality data, and data quality begins with participant trust. That trust is earned through a rigorous, transparent commitment to data usage and privacy and security. Our entire research infrastructure is built on a foundation of robust safeguards to ensure we protect participant data with the same diligence we apply to our scientific methods.”
A Verily-led survey of 2,000 consumers revealed 58% are interested in joining health research studies via their smartphone.1
Integrating diverse data. Bridging research and care.
Built on Verily Pre, an AI-native platform for precision health, the Lifelong Health Study enables integrated, multimodal data collection that goes beyond what traditional electronic health records (EHRs) can provide. By continuously gathering detailed information streams that EHRs often miss, we gain a more holistic and precise understanding of each person’s health over time. Pre, built on a FHIR-native approach, blends this complexity into actionable, reusable evidence enriched by clinical vocabularies with the goal to accelerate and improve clinical research for the advancement of new treatments and therapies.
The Lifelong Health Study will help provide critical insights that have historically limited both research and care. By capturing high-quality, longitudinal RWD across diverse populations, Verily is creating a foundation that brings the “bench to bedside” closer together in a way that is more realistic, scalable, and timely. This capability also helps ensure that future clinical practices and interventions are informed by deeper evidence drawn from actual lived health experiences.
Accelerating across the research lifecycle
Verily is redefining research through our Viewpoint Evidence solution capabilities that are partly enabled through the Lifelong Health Study. We provide researchers with a flexible and continuously updated resource that helps answer questions with unprecedented speed and clarity. Dr. Lehmann explains, "We’ve architected the Lifelong Health Study to be a living laboratory for the scientific community. Instead of the months or years it takes to stand up a new study, researchers can leverage this well-characterized, re-contactable cohort to significantly accelerate the research lifecycle through rapid testing of new hypotheses, deploying targeted surveys and more.”
Verily’s Viewpoint Evidence offerings also allow researchers to rapidly assemble tailored cohorts from our already existing, engaged participant base, allowing for investigation of safety signals or new hypotheses without the typical cost and delay of launching new studies.
Through successes from the Verily-led Baseline Health Study and Verily’s sponsorship of the new, Lifelong Health Study, we’re enabling rapid building of cohorts of consented participants who can be reengaged to unlock meaningful insights for retrospective and prospective studies.
Andrew Trister, MD, PhD,
Verily Chief Medical and Scientific Officer & Lifelong Health Study Principal Investigator
Ultimately, Verily’s Lifelong Health Study is poised to deliver RWD that is not simply generated, but continuously delivered, integrated, understood, and applied. This will provide pharmaceutical teams and other biomedical researchers with richer, faster insights and improve health in real time for more individuals, creating — a more complete picture of human health.
Up next — Closing GLP-1 data gaps in cardiometabolic care
Watch for our next article exploring how Verily’s flagship Cardiometabolic Cohort, the newly-launched Lifelong Health Study, and other evidence-generation capabilities can connect — and advance — research and care for diabetes, obesity, heart disease and beyond. Learn how integrating EHR data with insights from wearables, lifestyle signals, and participant surveys can help close critical cardiometabolic, clinical gaps, such as missing GLP-1 data. By revealing individual responses, adherence patterns, and side effect profiles, we can refine existing GLP-1 treatment, improve outcomes, and uncover new therapeutic opportunities.
Also, learn more about a new era of real-world evidence from Verily experts. Register for a live webinar, From Data Gaps to Dynamic Dialogue: A New Era of Real-World Evidence, scheduled on November 18, 2025, at 9:30 to 10:30 AM, PT.
Sources and disclaimers
1Verily data of file from company-led, online survey of 2,000 consumers, conducted July 11th to July 22nd, 2025.
Verily Me is not a medical device and has not been evaluated by the FDA.
